Two 510(k) records in the supplied collection list Nvision Biomedical Technologies as applicant, both under the orthopedic advisory committee and both decided as substantially equivalent. The Ntegrate Threaded Nail System, K261961, was received June 11, 2026 and decided October 14, 2026 under product code HWC. The EnHAnce PEEK Bunion System, K262098, was received June 22, 2026 and decided September 18, 2026 under product code HRS, with a Special clearance type. [1][2]

Documented 2026 clearances

K261961 covers the Ntegrate Threaded Nail System, a Traditional 510(k) with a Summary statement, reviewed by the orthopedic advisory committee and not reviewed by a third party. K262098 covers the EnHAnce PEEK Bunion System, a Special 510(k) with a Summary statement, also not third-party reviewed. Both filings list the applicant at 12449 Silicon Dr., San Antonio, Texas, an FDA filing address rather than a verified headquarters. [1][2]

A summary page for K262098 describes the subject device as adding a minimally invasive surgery configuration to an existing system, with the stated output being physical stabilization of bone segments and mechanical fixation of osteotomies. That summary reports bench testing only, with engineering analysis comparing mechanical performance of the subject implant against the predicate. [9]

Earlier filings under the same applicant name

FDA clearance letters in the public documents name Nvision Biomedical Technologies on earlier foot and ankle submissions. K250646, dated June 11, 2025, covers the Impact PEEK Union Nail System under 21 CFR 888.3040, Class II, product code HTY, with the common name PEEK, Pin, Fixation. K252657, dated September 19, 2025, covers the same trade name under the same regulation and product code. [6][8]

K250613, dated April 2, 2025, covers the SnapHammer Hammertoe Correction System under 21 CFR 888.3040, Class II, product code HWC. These letters identify the applicant at 4590 Lockhill Selma Rd, San Antonio, Texas, and name individual regulatory contacts; the addresses are filing correspondence addresses, not verified corporate headquarters. [7]

Company description and stated focus

Nvision's own website describes NVISION as a San Antonio-based medical device and biologics company that provides surgeons with implants and biologics intended to simplify and improve surgical procedures. The same page states a focus on foot and ankle health and cites more than 100 years of combined experience and a 2013 date. These are company-published claims, not independently verified facts. [5]

The site also states that NVISION implants are engineered to support bone integration and implant stability. No supplied source documents clinical outcomes, commercial availability, customers, certifications or ownership structure for the company or its products. [5]

How to read the collection

The supplied portfolio snapshot links two 510(k) records, both with a substantially equivalent decision, and the sample of those two records shows the same two decisions. These counts describe the supplied filings as of the snapshot date only; they are not measures of total company sales, total portfolio breadth or safety performance. No recall records appear in the supplied sample. [1][2]